Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001295345-16-000569
Filing Date
2016-05-16
Accepted
2016-05-16 14:18:31
Documents
42
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR THE PERIOD ENDED MARCH 31, 2016 owcp03312016.htm 10-Q 196521
2 EXHIBIT 31.1 exh31_1.htm EX-31 4035
3 EXHIBIT 31.2 exh31_2.htm EX-31 4033
4 EXHIBIT 32.1 exh32_1.htm EX-32 2050
5 EXHIBIT 32.2 exh32_2.htm EX-32 2075
  Complete submission text file 0001295345-16-000569.txt   992021

Data Files

Seq Description Document Type Size
6 owcp-20160331.xml EX-101.INS 112614
7 owcp-20160331.xsd EX-101.SCH 22932
8 owcp-20160331_cal.xml EX-101.CAL 1675
9 owcp-20160331_def.xml EX-101.DEF 12255
10 owcp-20160331_lab.xml EX-101.LAB 78958
11 owcp-20160331_pre.xml EX-101.PRE 64158
Mailing Address 22 SHAHAM STREET P.O. BOX 8324 PETACH TIQWA L3 4918103
Business Address 22 SHAHAM STREET P.O. BOX 8324 PETACH TIQWA L3 4918103 972-3-919-1921
OWC Pharmaceutical Research Corp. (Filer) CIK: 0001431934 (see all company filings)

EIN.: 980573566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54856 | Film No.: 161652699
SIC: 3841 Surgical & Medical Instruments & Apparatus